The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line treatment of metastatic NSCLC (mNSCLC) patients without actionable mutations in U.S. community oncology clinical practice.
 
Caroline McKay
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Ashwini Arunachalam
No Relationships to Disclose
 
Thomas A. Burke
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Xiting Cao
Employment - Merck
 
Amy P Abernethy
Employment - Flatiron Health
Leadership - Athenahealth; Flatiron Health
Stock and Other Ownership Interests - Athenahealth
Honoraria - Bristol-Myers Squibb; Helsinn Therapeutics; Merck
Consulting or Advisory Role - ACORN Research; Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb; Celgene; DARA BioSciences; GlaxoSmithKline; Helsinn Therapeutics; Pfizer
 
David Paul Carbone
Employment - James Cancer Center
Consulting or Advisory Role - Bayer; Biothera; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Genentech/Roche; Merck; Novartis; Peregrine Pharmaceuticals; Pfizer; Synta; Synta
Research Funding - Bristol-Myers Squibb